Last reviewed · How we verify

NCT06303089

Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients

Completed Last updated 23 April 2025
What this trial tests

trial testing Questionnaires set in Smoking Cessation in 567 participants. Completed in 15 April 2025.

Timeline
5 April 2024
Primary endpoint
31 January 2025
15 April 2025

Quick facts

Lead sponsorSun Yat-sen University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment567
Start date5 April 2024
Primary completion31 January 2025
Estimated completion15 April 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Sun Yat-sen University

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to describe the tobacco exposure and characteristics of patients with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking cessation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaires set

Trials testing the same drug.

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06303089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing